Joseph Galante, M.D., M.B.A., F.A.C.S., has been named interim chief medical officer elect to help ensure smooth transitions of patient care and quality outcomes. As multiple headwinds of inflation, supply chain inefficiencies, labor shortages, declining reimbursements, and physician burnout hinder the operational and financial performance of health systems care entities, it is essential to invest in innovation to achieve newfound operational efficiency. Chief Medical Officer Summit Creating Real Change in Total Cost-of-Care Requires Real Change in Specialty Care Ritz-Carlton, Pacific Promenade 3 This talk will provide an update on Amgens preclinical T-cell engager program and insights on what is coming down the pipeline. VP, Scientific Engagement, Sean Houshmandi, PhD The Inflation Reduction Acts initial prescription drug pricing provisions went live in January, and the high-profile Medicare drug negotiations begin in 2026. With advances in AI and machine learning, opportunities and use cases that leverage data harmonization, natural language processing, predictions, and generative models can help extract and summarize relevant information, close information gaps, and drive preventative care interventions. He will begin his role at the University of Arizona Sept. 5, reporting directly to me as a key member of the Universitys senior executive team. From the great resignation to quiet quitting to striking workers, there is significant turmoil within the health care workforce. Meet the 2023-24 chief residents | Department of Medicine, Three track choices covering new cell type approaches, neoantigen targeting approaches and clinical advancements. CEO & Scientific Founder, Customized, Multiplexed TCR-T cell Therapy for Solid Tumors, Novel Allogeneic iNKT Cells for Neoantigen Based Targets, Stephen Santoro, PhD Executive Director and Senior Fellow, Oncology Biomarker Development, Genentech, John Simmons, PhD Moderator: Richard Merkin, MD, Founder, President & CEO, Heritage Provider Network, The Role of Technology & Collaboration in Equitable Care Delivery Redesign Ritz-Carlton, Pavilions 4 & 5 The four major areas of cell therapy moving forward include autologous, allogeneic, point of care and In Vivo CAR-T. Key topics addressed: Emmett Schmidt, MD, PhD How are companies addressing those problems? Assistant Professor, Stem Cell Biology and Regenerative Medicine 2018 - 2021, John Douglas French Alzheimers Foundation Associate Professor of Stem Cell Biology and Regenerative Medicine, New York Stem Cell FoundationRobertson Investigator, & Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research, USC President & CEO, Camden Coalition of Healthcare Providers. Sweat is responsible for helping the company provide value to members, Senior Managing Director, HealthTech and Digital Health, SVB Securities. July 5, 2023, 10:36 AM PDT A woman standing in front of a corporate building with trees. CEO & Director, Scientific Affairs, Cancer Research Institute (CRI), Lisa Butterfield, PhD Panel: Novel Imaging Targets to Impact Immuno-Oncology. Scientific Leader, Immuno-Oncology Franchise, GE Healthcare Pharmaceutical Diagnostics, Kevin Maresca, PhD Reality: Addressing Translational Challenges in Immuno-Oncology Clinical Studies. Clinical trials have become the next frontier for advancing health equity. If we cannot see the complete picture of an episode, we cannot truly affect change. WebAcademic Year 2023-2024 P a g e | 1 Date: April 24, 2023 Vice President & Chief Medical Officer Re: Barnes-Jewish Hospital Memorandum of Appointment to House Staff 1. Global Product Leader Digital, Pharmaceutical Diagnostics, GE Healthcare, Travis Osterman, DO, MS CSO, Allogene Therapeutics. These include PSMA, Granzyme B, FAP and others. David Leung, MD, PhD Diederik Grootendorst, PhD And how can leaders across the industry come together to leverage past learnings and innovate on solutions to ensure a less volatile path forward?, Moderator: Tim Spilker, CEO, UnitedHealthcare Community & State, The Digital Mental Health Boom: Can New Solutions Improve Access and Ensure Quality? Its an opportunity to navigate from transactional moments to enduring relationships that drive loyalty and keep patients coming back. Brooklyn Heights is a neighborhood with more than 500 Antebellum homes and buildings. Chief Medical Officer Summit 360 2023 | HealthManagement.org If we cannot see the complete picture of an episode, we cannot truly affect change. Tracy Vanderslice An influx of investment from new players and technological advancement brings the opportunity for innovation and meaningful transformation to the forefront. How is neoadjuvant going to really shape patient management? Executive Director, Oncology Research, Amgen. CIO Leadership: An All-Star Roster of Business Tech Leaders Congratulations and thank you for being a long time advisor to #CMOSummit360! The ability to do this effectively relies on more than just technology or occasional doctor visits. Do you need some level of tumor mass to be there for the immune system to respond to so that you get a rip roaring, nice response that then protects you over time? Moderator: Monisha Machado-Pereira, Senior Partner, McKinsey & Company, Raising Capital and Spending Money in the New Normal Ritz-Carlton, Pacific Promenade 1 What imaging metrics can be employed, and what information do they provide? The Trouble With Trust: How Can Consumers Trust Us If We Dont Trust Them? Head, Heme Malignancies, Translational Research, Janssen R&D, Utility of Spatial Biology Tools in Drug Discovery and Development. summit Manager, Field Applications Scientist, Personalis, Inc, REVOLUTION Platform Trial Progress and Impact on the Treatment Landscape for Pancreatic Cancer. Galante assumed the elect role in February, will become Interim chief medical officer after Kirks retirement, and will serve in that role until at least the end of 2023. CEO, Scorpion Therapeutics. The CMO Summit 360 is the forum for Biotech CMOs to connect with peers and develop the skills needed to Bruce Levine, PhD Its imperative that care delivery redesign thoughtfully leverages the power of big data, AI/ML and automation to reduce health inequity., Moderator: Fatima Paruk, MD, Chief Health Officer and SVP, Healthcare & Life Sciences, Salesforce , Confab is a vital community of senior executives dedicated to strengthening organizational performance by advancing women in leadership and amplifying their cross-industry perspectives. Ritz-Carlton, Pacific Promenade Ballroom 3, An array of innovators are designing new models of digital and virtual care for mental health during a time of strain on the health care ecosystem. And second, accelerating innovation and redressing disparities amid the economic headwinds. Donoghue will take up the permanent position at Te Whatu Ora on 1 May 2023. We will explore and discuss what worked, what didnt work and what could be done differently in future trials to enable and drive the more efficient and effective development of future cell therapies. The unique capability of the DPX vaccine platform to package diverse immune cargo (Neo- and tumor-associated antigens, immune modulators) into a single formulation for delivery to APCs and flow through lymph nodes. The goal is to achieve better care coordination, well-being, and health outcomes, all while incorporating the patients preferences and choices. Part II of the Women Leadership in Bio webinar series will address Biotech Fundraising: Tales of Success and Failure. Senior Director, Immuno-Oncology and Cellular Therapy Translational Research. 2023 Speaker Presentations | The Conference Forum Amid these immense challenges, how can leaders truly meet the needs of all employees, build a safe environment, and advance diversity? Updates on the FDA Guidance and requirements for diversity plans. How you respond will impact patient care and the success of your business. Katie McCarthy, Chief Innovation Officer at Halloran Consulting Group, Inc. will moderate this webinar alongside other women leaders in life science as they share successful and not-so-successful examples of fundraising in this current macroeconomic environment. EVP, Head of Oncology, Lumanity, Sharon Benzeno, PhD Big Discussions will explore two overarching themes. Longeveron, a clinical stage biotechnology company developing treatments for age-related conditions and other ailments, has a new chief medical officer. The Summit is an invitation-only, premium Summit effectively uniting industry leaders in an exclusive networking environment on 23 - 24 February 2023 at the exquisite Four Seasons Resort and Club Dallas at Las Colinas, Dallas, TX, US. Moderator: Kris Joshi, PhD, CEO, Software, Network, and Data Solutions, Optum Insight, Realizing the Promise of Data Liberation Ritz-Carlton, Pacific Promenade 2 WebThe Chief Medical Officer Summit 360 celebrated its 10th year. 2023 Chief Medical Officer Conferences - DigiMarCon Top 10 Recommendations from Citis Expert Analyst, Dr Andrew Baum, Andrew Baum, MD Retirement party for J. Douglas Kirk spotlights 35 years of service Access the photos through the link in bio. Chief Medical Ofcer Summit Recap 2022 - The Conference In some areas of the world where resources are extremely limited and where there is not a lot of standard of care, clinical trials become a really attractive option for patients. Dr. John Maraganore, Alnylam Pharmaceuticals, Ken Getz, Tufts University, and Jessica Chutter, Morgan Stanley. U.N. summit discusses how to use A.I. for good | CNN IO360 is pleased to welcome newly minted Nobel Laureate Dr Carolyn Bertozzi who will share how her work in bioorthogonal and click chemistry is being applied to help advance cancer immunotherapy research. GET IN February 28, 2023. Senior Director, ICT Development, The Development of Vdelta1 Gamma Delta T Cell Platforms for use in Next Generation Allogeneic CAR Therapies, Nandhu Sobhana, PhD Solving total cost-of-care challenges requires significant attention on specialty care and an innovative approach with payers and providers. Terms and Conditions, Investor Perspective on the State of the Current Market and Impact on the IO Cell Therapy Field, Senior Director, Immuno-Oncology and Cellular Therapy Translational Research, Core Faculty Member / Associate Professor of Biology / Associate Professor of Neuroscience and Physiology. Hotels Flights Rides Keep up with our latest news and events. Which all makes for a timely moment to pull up on the health policy landscape. You can read more in our, The 3rd Saudi international Pharma & Medlab Expo 2023, 4th Aligning Drug Safety Functions & REMS Summit. The ctDNA to Monitor Treatment Response (ctMoniTR) Project is a unique partnership led by Friends of Cancer Research to answer the important question: Do changes in ctDNA reflect response to treatment? CHIEF What does it take to get a Series A and/or a partnership in this current investing environment? AI in Health Care: Maximizing Reward While Mitigating Risk Ritz-Carlton, Pacific Promenade 1 In this fireside chat, Dr Tal Zaks will discuss the history of mRNA use in cancer, ways companies may be underutilizing their capital, and where mRNA is likely to have the highest impact in oncology. Join leading care delivery and health technology experts to explore collaborative strategies to truly unlock the potential of AI to improve primary care outcomes., Moderator: Paul Muret, VP & GM Google Health Care Studio, Thriving Not Just Surviving: A New Playbook for Financial Transformation Ritz-Carlton, Pacific Promenade 1 This is the conference to network with other biotech CMOs across indications, company stages and geographic locations. Its imperative that care delivery redesign thoughtfully leverages the power of big data, AI/ML and automation to reduce health inequity.. Confab is a vital community of senior executives dedicated to strengthening organizational performance by advancing women in leadership and amplifying their cross-industry perspectives. Christelle Johnson, PhD Clean-up on IL-2: How to Combine and Target Natural Cytokine Biologys to the Tumor Microenvironment and Select Patients Based on Immune Fitness, Pavel Khrimian, MBA VP, Cellular Therapy, Janssen Pharmaceuticals, Roundtable #4: CAR-T Development in China: What we Need to Know, Regulatory Considerations and Impact on the Field. WebWe are excited to announce the 2023 Chief Medical Officer 360 Keynotes! And more importantly, how do cross-industry leaders maximize opportunities for engaging and benefitting underserved communities in clinical trial participation, recognizing the legacy of discrimination and mistrust? And at the same time, Medicare Advantage remains in the spotlight, with CMS finalizing rules to claw back past overpayments and proposing changes to the risk-adjustment model moving forward. Displayed a favorable single-dose PK profile; and demonstrated strong combinatorial anti-tumor activity with anti-PD-1. #CMOSummit360#conference#biotech#CMO360#chiefmedicalofficer#summit#connection#physicians#CMO. And more importantly, how do cross-industry leaders maximize opportunities for engaging and benefitting underserved communities in clinical trial participation, recognizing the legacy of discrimination and mistrust?, Moderator: Carolyn Starrett, CEO, Flatiron Health, Emcee: Rob Lazerow, EVP, Health Evolution, Amy Abernethy, MD, PhD, President of Product Development & Chief Medical Officer, Verily; former Principal Deputy Commissioner, FDA, in discussion with Joaquin Duato, Chairman & CEO, Johnson & Johnson. We are excited to announce the 2023 Chief Medical Officer 360 Keynotes! We will explore some of the principles and mechanisms that drive success and failure of this exciting treatment modality. Christine Ward, PhD VP, Development Program Lead, Cell Therapy Development, BMS, William Ho, MBA Chief Commercial Officer, Immune Medicine, Developing Best-in-class Allogeneic CAR-T Cell Therapies Using Next-generation CRISPR Genome-editing Technology, Advancing Towards an Allo Therapy for Solid Tumors, William Ho, MBA Andrew Allen, MD, PhD Moderator: Lisa Collins, CEO, Optum Advisory Services Join Confabs Big Discussion, where cross-industry CEOs will examine how to effectively confront these workforce challenges., Moderator: Carladenise Edwards, PhD, Strategic & Board Advisor, Parsley Health, Clover Health, and Heluna Health. Given these realities, leaders are examining how to leverage technology and automation better, rethinking their key performance metrics, and exploring avenues to diversify revenue streams.